explore -WSS

explore

author：entertainment 2025-09-06 04:26:51 - browse：4128

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

WSS

AstraZeneca challenges Medicare drug negotiation program

AstraZeneca bets AAV gene therapy will still deliver the goods

CDC advisory panel says seniors 'may' get RSV vaccine

Complete sequence of Y chromosome published for first time

Carbon Health diabetes program, a test of data

What health policies could hitch a ride on a spending bill?

explore

explore

focus

Apple is now the first public company to be valued at $3 trillion

How Long Island became the ‘eugenics capital of the world’

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Zepbound, Valneva's vaccine, and more

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

First transplant of an entire human eye performed

How one medical school became remarkably diverse

Ohio still needs to do more to protect the right to abortion

Jerome Adams on the need for new antivirals for Covid

FDA panel gives mixed vote on blood pressure devices

knowledge

Winners, losers from Medicare’s list of drugs subject to price talks

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Medicare explains how it will choose drugs for negotiation

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Weight loss drugs should be covered by insurers, AMA says

What health policies could hitch a ride on a spending bill?

knowledge

focus

focus

hotspot